|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006837,
umls-concept:C0022877,
umls-concept:C0030705,
umls-concept:C0205210,
umls-concept:C0205329,
umls-concept:C0239295,
umls-concept:C0370215,
umls-concept:C0537894,
umls-concept:C0683598,
umls-concept:C1274040,
umls-concept:C1301820,
umls-concept:C1697858,
umls-concept:C2348628
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-3-29
|
|
pubmed:abstractText |
A patient with azole-refractory thrush-esophagitis responded initially to caspofungin, but the treatment eventually failed. In a murine model, caspofungin was effective against two early isolates for which the MICs of caspofungin were low, but it was less effective against a late isolate for which the MIC of caspofungin was greater. We concluded that there is a correlation between in vivo failure and rising in vitro caspofungin MICs.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-10722525,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-11557454,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-11796357,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-12490683,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-12604543,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-7695288,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-7935701,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-8239594,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-8239613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-8457977,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-8641300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-8718616,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-9371352,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15047549-9797228
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1382-3
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15047549-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:15047549-Adult,
pubmed-meshheading:15047549-Animals,
pubmed-meshheading:15047549-Antifungal Agents,
pubmed-meshheading:15047549-Candida albicans,
pubmed-meshheading:15047549-Candidiasis,
pubmed-meshheading:15047549-Drug Resistance, Fungal,
pubmed-meshheading:15047549-Echinocandins,
pubmed-meshheading:15047549-Esophagitis,
pubmed-meshheading:15047549-Humans,
pubmed-meshheading:15047549-Male,
pubmed-meshheading:15047549-Mice,
pubmed-meshheading:15047549-Mice, Inbred ICR,
pubmed-meshheading:15047549-Microbial Sensitivity Tests,
pubmed-meshheading:15047549-Peptides,
pubmed-meshheading:15047549-Peptides, Cyclic,
pubmed-meshheading:15047549-Treatment Failure
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis.
|
|
pubmed:affiliation |
Department of Medicine, Division Infectious Diseases (7881), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. Hernandezs@uthscsa.edu
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
